Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CRISPR-Cas Systems | 7 | 2024 | 293 | 1.780 |
Why?
|
| Gene Editing | 5 | 2024 | 212 | 1.670 |
Why?
|
| Mice, Knockout | 9 | 2025 | 3873 | 0.760 |
Why?
|
| Testicular Neoplasms | 3 | 2021 | 131 | 0.740 |
Why?
|
| Embryonic Germ Cells | 3 | 2021 | 9 | 0.680 |
Why?
|
| Teratoma | 3 | 2021 | 130 | 0.620 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 69 | 0.570 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 160 | 0.530 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 18 | 0.490 |
Why?
|
| Cyclin D1 | 1 | 2016 | 113 | 0.480 |
Why?
|
| Mice | 26 | 2025 | 18566 | 0.470 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2012 | 239 | 0.430 |
Why?
|
| Neoplastic Stem Cells | 2 | 2012 | 348 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 634 | 0.380 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 4694 | 0.370 |
Why?
|
| Animals | 26 | 2025 | 34953 | 0.350 |
Why?
|
| Genes, Essential | 2 | 2024 | 43 | 0.260 |
Why?
|
| Exons | 4 | 2023 | 802 | 0.240 |
Why?
|
| Oocytes | 2 | 2024 | 291 | 0.230 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 18 | 0.230 |
Why?
|
| Alleles | 5 | 2024 | 1684 | 0.230 |
Why?
|
| RANK Ligand | 1 | 2025 | 54 | 0.220 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 17 | 0.220 |
Why?
|
| Viral Tropism | 1 | 2025 | 53 | 0.220 |
Why?
|
| Zygote | 1 | 2024 | 30 | 0.210 |
Why?
|
| Cell Differentiation | 4 | 2025 | 1975 | 0.210 |
Why?
|
| Osteoblasts | 1 | 2025 | 161 | 0.210 |
Why?
|
| Dependovirus | 1 | 2025 | 154 | 0.200 |
Why?
|
| Mice, Transgenic | 6 | 2024 | 2453 | 0.200 |
Why?
|
| DNA Helicases | 1 | 2025 | 241 | 0.200 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 2 | 2023 | 111 | 0.200 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 175 | 0.200 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 342 | 0.200 |
Why?
|
| Integrases | 1 | 2023 | 159 | 0.190 |
Why?
|
| Neural Stem Cells | 1 | 2023 | 151 | 0.190 |
Why?
|
| Embryonal Carcinoma Stem Cells | 2 | 2021 | 9 | 0.190 |
Why?
|
| Germ Cells | 1 | 2023 | 204 | 0.190 |
Why?
|
| Bone and Bones | 2 | 2021 | 301 | 0.180 |
Why?
|
| Genetic Association Studies | 3 | 2020 | 856 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 215 | 0.180 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 14 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 323 | 0.180 |
Why?
|
| Coatomer Protein | 1 | 2021 | 30 | 0.180 |
Why?
|
| Sex Differentiation | 1 | 2021 | 20 | 0.180 |
Why?
|
| Endometriosis | 1 | 2024 | 174 | 0.180 |
Why?
|
| Genetic Vectors | 1 | 2025 | 927 | 0.170 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 97 | 0.170 |
Why?
|
| Osteoporosis | 1 | 2021 | 138 | 0.160 |
Why?
|
| Mice, 129 Strain | 2 | 2018 | 99 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 701 | 0.160 |
Why?
|
| Population Health | 1 | 2020 | 40 | 0.160 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 12 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 61 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1132 | 0.150 |
Why?
|
| Disease | 1 | 2020 | 126 | 0.150 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 68 | 0.150 |
Why?
|
| Nuclear Proteins | 1 | 2025 | 1285 | 0.140 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 72 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2019 | 454 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 749 | 0.120 |
Why?
|
| Leydig Cells | 1 | 2016 | 21 | 0.120 |
Why?
|
| Female | 11 | 2025 | 70680 | 0.120 |
Why?
|
| Retroviridae Infections | 2 | 2012 | 10 | 0.120 |
Why?
|
| Male | 10 | 2025 | 64918 | 0.120 |
Why?
|
| Sertoli Cells | 1 | 2016 | 79 | 0.120 |
Why?
|
| Meiosis | 1 | 2016 | 116 | 0.120 |
Why?
|
| DNA Damage | 1 | 2019 | 513 | 0.120 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2012 | 101 | 0.120 |
Why?
|
| Intestinal Polyposis | 1 | 2015 | 18 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 293 | 0.120 |
Why?
|
| Mitosis | 1 | 2016 | 201 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2021 | 2512 | 0.120 |
Why?
|
| Software | 1 | 2020 | 729 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2017 | 527 | 0.110 |
Why?
|
| Tumor Virus Infections | 2 | 2012 | 140 | 0.110 |
Why?
|
| Gene Expression | 2 | 2017 | 1564 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 387 | 0.110 |
Why?
|
| Interleukins | 1 | 2015 | 129 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 241 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1093 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2025 | 1019 | 0.100 |
Why?
|
| Neurons | 1 | 2023 | 2016 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1333 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2023 | 2494 | 0.100 |
Why?
|
| Mutation | 2 | 2024 | 6249 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 264 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2019 | 1581 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4764 | 0.090 |
Why?
|
| Mutagenesis | 2 | 2023 | 347 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 637 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3698 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 138 | 0.070 |
Why?
|
| Phenotype | 3 | 2024 | 4541 | 0.070 |
Why?
|
| Zebrafish | 2 | 2021 | 420 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2064 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2021 | 877 | 0.060 |
Why?
|
| Humans | 12 | 2025 | 132105 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 13 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 13 | 0.060 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 605 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3358 | 0.060 |
Why?
|
| Bone Development | 1 | 2025 | 55 | 0.060 |
Why?
|
| Serogroup | 1 | 2025 | 63 | 0.060 |
Why?
|
| Osteoclasts | 1 | 2025 | 72 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2025 | 383 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 294 | 0.050 |
Why?
|
| Transgenes | 1 | 2025 | 336 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2024 | 164 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 124 | 0.050 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2023 | 67 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 544 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2023 | 197 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2018 | 806 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 173 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2023 | 93 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2023 | 191 | 0.050 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2023 | 156 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2023 | 221 | 0.050 |
Why?
|
| Progesterone | 1 | 2024 | 450 | 0.050 |
Why?
|
| Estrogens | 1 | 2024 | 435 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 77 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 95 | 0.040 |
Why?
|
| Endometrium | 1 | 2024 | 274 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 123 | 0.040 |
Why?
|
| Spermatogonia | 1 | 2021 | 33 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 145 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 579 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2023 | 404 | 0.040 |
Why?
|
| Brain | 2 | 2023 | 3201 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 681 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 221 | 0.040 |
Why?
|
| Genome | 1 | 2023 | 502 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2025 | 720 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 96 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 270 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 623 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 691 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 78 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 699 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 130 | 0.040 |
Why?
|
| Sex Determination Processes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 1038 | 0.030 |
Why?
|
| Amino Acids | 1 | 2020 | 626 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 288 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1556 | 0.030 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2017 | 90 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 4725 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 449 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2015 | 68 | 0.030 |
Why?
|
| Mast Cells | 1 | 2015 | 67 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2015 | 189 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2021 | 14718 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1723 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 1256 | 0.030 |
Why?
|
| Colonic Polyps | 1 | 2015 | 83 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 257 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 3061 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 3083 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 1735 | 0.020 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2012 | 36 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 250 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1046 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 1651 | 0.020 |
Why?
|
| Wound Healing | 1 | 2015 | 480 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2706 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2015 | 903 | 0.020 |
Why?
|
| Child | 2 | 2021 | 25758 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1292 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2851 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 615 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1124 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1904 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2679 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 9940 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 20532 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31557 | 0.010 |
Why?
|